1
|
Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast.
|
Nat Nanotechnol
|
2010
|
2.17
|
2
|
Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics.
|
Acc Chem Res
|
2011
|
1.45
|
3
|
Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation.
|
J Biomed Mater Res A
|
2010
|
1.31
|
4
|
Enabling individualized therapy through nanotechnology.
|
Pharmacol Res
|
2010
|
1.28
|
5
|
Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.
|
Trends Pharmacol Sci
|
2010
|
1.22
|
6
|
Intracellular trafficking of silicon particles and logic-embedded vectors.
|
Nanoscale
|
2010
|
1.15
|
7
|
Multistage Mesoporous Silicon-based Nanocarriers: Biocompatibility with Immune Cells and Controlled Degradation in Physiological Fluids.
|
Controll Release Newsl
|
2008
|
0.93
|
8
|
Inter-endothelial transport of microvectors using cellular shuttles and tunneling nanotubes.
|
Small
|
2012
|
0.87
|
9
|
Activation of the inflammasome and enhanced migration of microparticle-stimulated dendritic cells to the draining lymph node.
|
Mol Pharm
|
2012
|
0.86
|
10
|
1H NMR Detection of superparamagnetic nanoparticles at 1T using a microcoil and novel tuning circuit.
|
J Magn Reson
|
2006
|
0.83
|
11
|
Effects of Near-infrared Laser Irradiation of Biodegradable Microspheres Containing Hollow Gold Nanospheres and Paclitaxel Administered Intraarterially in a Rabbit Liver Tumor Model.
|
J Vasc Interv Radiol
|
2012
|
0.83
|
12
|
Analysis of the influence of cell heterogeneity on nanoparticle dose response.
|
ACS Nano
|
2014
|
0.81
|
13
|
The physiology of cardiovascular disease and innovative liposomal platforms for therapy.
|
Int J Nanomedicine
|
2013
|
0.81
|
14
|
Porous silicon advances in drug delivery and immunotherapy.
|
Curr Opin Pharmacol
|
2013
|
0.81
|
15
|
Adjuvant cationic liposomes presenting MPL and IL-12 induce cell death, suppress tumor growth, and alter the cellular phenotype of tumors in a murine model of breast cancer.
|
Mol Pharm
|
2014
|
0.77
|
16
|
Preparation, characterization, and cellular associations of silicon logic-embedded vectors.
|
Methods Enzymol
|
2012
|
0.75
|
17
|
Reduced Cationic Nanoparticle Cytotoxicity Based on Serum Masking of Surface Potential.
|
J Biomed Nanotechnol
|
2016
|
0.75
|